LMR Partners’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBP
JHC
LMR Partners's CRBP Position: Q3 2026 in Review
LMR Partners held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2026 at 35,500 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1344.
LMR Partners first reported a position in CRBP in Q2 2021 and has held it in 3 quarters since. The position peaked at $333K in Q2 2026. 120 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.
- LMR Partners held 35,500 shares of Corbus Pharmaceuticals worth $242K as of Q3 2026.
- LMR Partners left its Corbus Pharmaceuticals share count unchanged in Q3 2026.
- Corbus Pharmaceuticals made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1344 holding.
- LMR Partners first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
- LMR Partners's Corbus Pharmaceuticals position peaked at $333K in Q2 2026.
- 120 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.